Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IONQ vs MRNA✓SelectedUSD · MRNAIONQ vs MRNA performance historyLatest closeAs of-8.76%11/20
Stock and ETF performance explorer

IONQ vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+61.2%
MRNA return
+153.9%
Excess return
-92.7%
Maximum drawdown
-74.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.8%-2.2%-6.6%-8.6%
7D-28.3%-12.7%-15.6%-27.3%
30D-35.8%-20.7%-15.1%-34.3%
3M-50.1%+46.3%-96.4%-51.7%
6M-60.5%+305.2%-365.7%-69.7%
YTD-53.8%+561.2%-615.1%-70.2%
1Y-49.5%+772.1%-821.6%-70.2%
3Y+61.2%+147.0%-85.7%+10.7%
All+61.2%+153.9%-92.7%+10.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling